Bartoletti, Michele
 Distribuzione geografica
Continente #
NA - Nord America 4.083
AS - Asia 3.388
EU - Europa 734
SA - Sud America 714
Continente sconosciuto - Info sul continente non disponibili 183
AF - Africa 66
OC - Oceania 9
Totale 9.177
Nazione #
US - Stati Uniti d'America 3.934
SG - Singapore 1.765
CN - Cina 757
BR - Brasile 585
VN - Vietnam 412
IT - Italia 220
HK - Hong Kong 120
IE - Irlanda 101
FI - Finlandia 91
CA - Canada 70
DE - Germania 48
GB - Regno Unito 48
BD - Bangladesh 47
RU - Federazione Russa 44
IN - India 42
MX - Messico 42
AR - Argentina 39
FR - Francia 37
MY - Malesia 35
IQ - Iraq 30
EC - Ecuador 28
NL - Olanda 28
JP - Giappone 27
ID - Indonesia 25
PL - Polonia 24
ZA - Sudafrica 23
ES - Italia 22
CO - Colombia 15
TR - Turchia 15
PE - Perù 12
PK - Pakistan 12
PY - Paraguay 12
UZ - Uzbekistan 12
SA - Arabia Saudita 11
SE - Svezia 10
EG - Egitto 9
JM - Giamaica 9
PH - Filippine 9
UA - Ucraina 9
VE - Venezuela 9
AU - Australia 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
MA - Marocco 7
NP - Nepal 7
IR - Iran 6
KE - Kenya 6
KR - Corea 6
RS - Serbia 6
TN - Tunisia 6
AT - Austria 5
BG - Bulgaria 5
BH - Bahrain 5
CR - Costa Rica 5
AL - Albania 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
JO - Giordania 4
KZ - Kazakistan 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
GR - Grecia 3
LV - Lettonia 3
NI - Nicaragua 3
PA - Panama 3
PS - Palestinian Territory 3
BE - Belgio 2
DK - Danimarca 2
GT - Guatemala 2
GY - Guiana 2
HN - Honduras 2
KG - Kirghizistan 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
TJ - Tagikistan 2
TT - Trinidad e Tobago 2
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EE - Estonia 1
ER - Eritrea 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
Totale 8.986
Città #
Dallas 933
Singapore 698
Ashburn 603
San Jose 455
The Dalles 314
Shanghai 250
Council Bluffs 191
Los Angeles 151
New York 143
Santa Clara 143
Boardman 134
Ho Chi Minh City 132
Beijing 118
Hong Kong 113
Dublin 101
Helsinki 91
Hanoi 82
Milan 67
São Paulo 57
Buffalo 49
Phoenix 32
Toronto 24
Da Nang 23
Rio de Janeiro 23
Orem 22
Rome 22
Haiphong 20
Moscow 20
Seattle 20
Warsaw 20
Mexico City 19
Tokyo 18
Kuala Lumpur 17
Brooklyn 16
Chicago 16
Baghdad 15
Montreal 15
Chandler 14
Curitiba 14
Dhaka 14
Brasília 13
Amsterdam 12
Assago 12
Charlotte 12
Johannesburg 12
Atlanta 11
Boston 11
Chennai 11
Cuenca 11
Tashkent 11
Belo Horizonte 10
Hangzhou 10
Riverside 9
Bắc Ninh 8
Cairo 8
Jeddah 8
London 8
Manchester 8
Philadelphia 8
San Francisco 8
Wilmington 8
Houston 7
Lima 7
Paris 7
Pasadena 7
Queens 7
Quito 7
Asunción 6
Frankfurt am Main 6
Genoa 6
Guangzhou 6
Hải Dương 6
Miami 6
Nairobi 6
Naples 6
Porto Alegre 6
Quảng Ngãi 6
Ribeirão Preto 6
Sorocaba 6
Stockholm 6
Turin 6
Vũng Tàu 6
Ankara 5
Biên Hòa 5
Go Vap 5
Guayaquil 5
Ha Long 5
Hillsboro 5
Manaus 5
Mauá 5
Princeton 5
Quảng Ninh 5
Ribeirão das Neves 5
San Pablo 5
São Luís 5
Thái Nguyên 5
Wuhan 5
Addis Ababa 4
Baltimore 4
Barcelona 4
Totale 5.637
Nome #
What is the impact of anti-enterococcal empirical therapy on survival of patients with enterococcal bloodstream infections? 440
COVID-19 Vaccination Still Makes Sense: Insights on Pneumonia Risk and Hospitalization from a Large-Scale Study at an Academic Tertiary Center in Italy 386
Beyond the distance between juridic and scientific decision-making process: An evidence-based prediction algorithm for professional liability assessment in healthcare-associated infections 132
Ischemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis 112
Carbapenem-resistant bacteria in an intensive care unit during the coronavirus disease 2019 (COVID-19) pandemic: A multicenter before-and-after cross-sectional study 108
Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant staphylococcus aureus bloodstream infections: a narrative review exploring past, present, and future 95
Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS‐CoV‐2 infection 94
Blood Hemoglobin Substantially Modulates the Impact of Gender, Morbid Obesity, and Hyperglycemia on COVID-19 Death Risk: A Multicenter Study in Italy and Spain 89
Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation 88
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 87
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 82
Meningitis caused by toscana virus is associated with strong antiviral response in the CNS and altered frequency of blood antigen-presenting cells 82
Management of Metastatic Endometrial Cancer: Physicians’ Choices Beyond the First Line. A MITO Survey 81
The long Pentraxin PTX3 serves as an early predictive biomarker of co-infections in COVID-19 79
Bloodstream infections in patients with liver cirrhosis 76
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 73
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis 72
Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study 71
Epidemiology and Resistance Profiles of Bacteria Isolated From Blood Samples in Septic Patients at Emergency Department Admission: A 6-Year Single Centre Retrospective Analysis From Northern Italy 70
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 68
A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients 68
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 67
Antifungal prophylaxis in liver transplant recipients: one size does not fit all 67
CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE – a multi-centre experience in Italy 66
Advances in the therapy of bacterial bloodstream infections 65
Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure 63
Risk factors for recurrent carbapenem resistant Klebsiella pneumoniae bloodstream infection: a prospective cohort study 63
Treatment duration for Escherichia coli bloodstream infection and outcomes: Retrospective single-centre study 63
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 63
2018 WSES/SIS-E consensus conference: Recommendations for the management of skin and soft-tissue infections 63
Statin therapy decreases serum levels of high-sensitivity C-reactive protein and tumor necrosis factor-alpha in HIV-infected patients treated with ritonavir-boosted protease inhibitors 62
Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae 62
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups 62
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 62
An Antimicrobial Stewardship Program Based on Systematic Infectious Disease Consultation in a Rehabilitation Facility 62
Management of metastatic endometrial cancer: physicians’ choices beyond the first line after approval of checkpoint inhibitors 62
Use of critical care resources during the first 2 weeks (February 24–March 8, 2020) of the Covid-19 outbreak in Italy 62
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 61
Prevention of infections in nursing homes: Antibiotic prophylaxis versus infection control and antimicrobial stewardship measures 61
A descriptive case series of PK/PD target attainment and microbiological outcome in critically ill patients with documented severe XDR Acinetobacter baumannii BSI and/or VAP treated with cefiderocol 61
Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations 60
Impact of a hospital-wide multifaceted programme for reducing carbapenem-resistant Enterobacteriaceae infections in a large teaching hospital in northern Italy 59
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy 58
Distinct chromosomal mutation associated with cefiderocol resistance in Acinetobacter baumannii: a combined bioinformatics and mass spectrometry approach to unveil and validate the in vivo-acquired chemoresistance 58
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection: a multicentre cohort study (PREDI-CO study) 58
In vivo evolution of resistant subpopulations of KPC-producing Klebsiella pneumoniae during ceftazidime/avibactam treatment 57
Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience 57
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 57
Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors 56
Opportunistic infections in end stage liver disease 56
High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation 56
A retrospective multicentre study on dalbavancin effectiveness and cost-evaluation in sternotomic wound infection treatment: DALBA SWIT Study 56
Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape 56
Carbapenemase-producing Enterobacteriaceae in transplant patients 56
Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study 55
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22) 55
Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study 55
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 54
Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort 54
Differences in the rate of carbapenem-resistant Enterobacteriaceae colonisation or Clostridium difficile infection following frontline treatment with tigecycline vs. meropenem for intra-abdominal infections 54
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 54
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial 54
COVID-19-associated pulmonary aspergillosis, March-August 2020 53
Toscana virus infections in northern Italy: laboratory and clinical evaluation 53
Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing Klebsiella pneumoniae Causing Bloodstream Infections in Northern Italy, 2018 53
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 53
Dialysis-associated infection prevention and surveillance trial: an easy, feasible and effective bundle for infection prevention 53
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 53
Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications 53
Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy 51
Serum bactericidal titres for monitoring antimicrobial therapy: current status and potential role in the management of multidrug-resistant Gram-negative infections 51
How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre 51
ESCMID COVID-19 living guidelines: drug treatment and clinical management 51
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 51
Klebsiella pneumoniae bloodstream infection epidemiology and impact of inappropriate empirical therapy 51
Increase in invasive group A streptococcal infections in Milan, Italy: a genomic and clinical characterization 51
Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study 50
Epidemiology and outcomes of bloodstream infection in patients with cirrhosis 50
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: A prospective observational multicentre study 50
Clinical experience with dalbavancin for the treatment of deep sternal wound infection 50
Risk factors for candidemia in hospitalized patients with liver cirrhosis: a multicenter case-control-control study 49
Microbiology of periprosthetic infections following implant-based breast reconstruction surgery: a multicentric retrospective study 49
Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study 49
Carbapenem-resistant Klebsiella pneumoniae colonization at liver transplantation:a management challenge 49
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 49
What do clinicians mean by epidemics' preparedness 49
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 48
Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation 47
The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study 47
Critically ill patients with COVID-19 show lung fungal dysbiosis with reduced microbial diversity in Candida spp colonized patients 47
Ursodeoxycholic Acid Does Not Improve COVID-19 Outcome in Hospitalized Patients 47
Outcome of early treatment of SARS‐CoV‐2 infection in patients with haematological disorders 46
Role of liposomal amphotericin B in intensive care unit: an expert opinion paper 46
Management of bacterial and fungal infections in cirrhosis: The MDRO challenge 46
The Gut Microbiota of Critically Ill Patients With COVID-19 46
COVID-19 in solid organ transplant recipients: No difference in survival compared to general population 46
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 45
Use of meropenem in treating carbapenem-resistant Enterobacteriaceae infections 45
Risk factors for persistent enterococcal bacteraemia: a multicentre retrospective study 45
Risk Factors for Infection With Carbapenem-Resistant Klebsiella pneumoniae After Liver Transplantation: The Importance of Pre- and Posttransplant Colonization 45
Totale 6.753
Categoria #
all - tutte 49.729
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.729


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 1 0 0 0 1 0 0 2 0
2022/2023148 6 0 3 5 1 5 0 5 6 3 111 3
2023/20241.048 65 70 204 37 62 171 89 52 17 51 118 112
2024/20251.580 31 8 19 39 35 203 89 97 285 467 141 166
2025/20265.706 556 617 832 397 227 252 1.213 242 246 385 329 410
2026/2027680 373 307 0 0 0 0 0 0 0 0 0 0
Totale 9.177